In response to the devastation wrought by Saturday’s earthquake and powerful aftershocks in Nepal, the Ad Council has joined the U.S. Agency for International Development’s Center for International Disaster Information (USAID CIDI) to launch a series of television, print and digital public service advertisements (PSAs) encouraging Americans to make financial contributions to disaster relief efforts. The PSAs direct audiences to visit CIDI.org/NepalRelief, where they can contribute to support the short and long-term recovery operations, providing supplies and services to those affected by the earthquake.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7512851-ad-council-nepal-earthquake-relief/
Wildfires are a serious risk to property and lives in every state in the country. Last year alone the National Interagency Fire Center (NIFC) reported there were 63,212 fires in the U.S. and Puerto Rico that burned 3,595,613 million acres – that’s roughly the size of Connecticut! In an effort to help raise community and homeowner awareness about preparing for wildfires, State Farm and the National Fire Protection Association (NFPA) are working together and encouraging residents to take action during national Wildfire Community preparedness Day.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7452831-state-farm-weather-preparedness/
Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that many retina specialists throughout the U.S. are now using ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg to treat patients with diabetic macular edema (DME). The first injections of ILUVIEN in the U.S. were captured during a live web event attended by more than 250 eye care professionals. ILUVIEN is the first multiyear eye implant designed to deliver a continuous, submicrogram daily dose of steroid to the retina for 36 months with one injection. ILUVIEN is indicated for the treatment of DME in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7496251-iluvien-dme/
Every three minutes someone in the U.S. is diagnosed with a blood cancer. No one knows this better than “Nashville” star Charles Esten and his wife Patty. Esten’s 15-year-old daughter, Addie, was diagnosed with leukemia at age 2 ½. Naturally, their world was turned upside down. But, they quickly learned that there was hope, based on research to advance new treatments and cures for leukemia, much of it funded by The Leukemia & Lymphoma Society (LLS).
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7491051-charles-esten-light-the-night-walks/
Since ancient times, the egg has been regarded as a symbol of new life and has been associated with springtime celebrations, such as Easter and Passover. But, even during festive occasions, eggs can cause food poisoning (also called foodborne illness) if they are not handled properly. That’s why the U.S. Food and Drug Administration (FDA) reminds consumers to handle fresh eggs safely during their springtime celebrations and throughout the year.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7231951-u-s-fda-egg-safety/
The Department of Transportation’s National Highway Traffic Safety Administration (NHTSA) today announced its first-ever, national advertising campaign aimed at parents of children ages 8-14 to make sure their kids are consistently and properly wearing their seat belt every time the car is moving.
“Buckling up is an important habit to instill in children at a young age. As parents, we need to lead by example and reinforce the message to make sure it sticks,” said U.S. Transportation Secretary Anthony Foxx. “This campaign urges parents to never give up until their kids buckle up.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7467951-psa-kids-seat-belt-safety-ad-council/
The current student loan debt crisis in the U.S. is real. Total student loan debt currently stands at more than $1.16 trillion. And, according to the Federal Reserve Bank of New York, student loans represent the highest amount of delinquent debt compared to all other forms of household debt, including mortgages, auto loans, and credit cards.
Gaining a college education has long been among the most important first steps towards obtaining a happy and prosperous life. The reality, however, is that most college graduates are starting their adult life deep in debt, and feeling stressed and completely unprepared to manage their financial lives. The good news is that the government has created programs to help borrowers reduce the burden caused by student loan debt. To learn more about these government programs, visit StudentAid.ed.gov.
Money Management International (MMI), along with other nonprofit organizations and consumer advocate groups, have taken additional steps to help struggling student loan borrowers understand their repayment plan options, find solutions for managing other debt obligations, and create realistic action plans for reaching overall financial success.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7406151-mmi-student-loan-debt/
Chiasma, Inc., a U.S. privately–held biopharma company developing octreotide capsules for the orphan condition acromegaly, today announced two new studies presented at the 97th Endocrine Society (ENDO) Annual Meeting in San Diego, Calif. The studies provide additional data from Chiasma’s Phase III trial and new findings on the patient burden of current injection therapies.
“We now have data to help clinicians determine whether octreotide capsules, if approved, are likely to help their patient with acromegaly maintain response,” said Shlomo Melmed, M.D., senior vice president and dean, Cedars–Sinai Medical Center, Los Angeles and global study principal investigator. “Furthermore, the Phase III results show the safety and efficacy of octreotide capsules can be reliably determined within 12 weeks of initiating therapy.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7436451-endo-chiasma-clinical-data/
One in four children has an undetected vision problem, and ten million American students have vision conditions that can impact learning. An annual comprehensive eye exam can ensure that correctable visual problems don’t become permanent. What if your vision insurance helped more people see? VSP® Vision Care, the largest not-for-profit vision benefits and services company in the U.S., is doing just that by launching #EyeGiveBack. Now through June 30, 2015, when a VSP Direct™ individual vision insurance plan is purchased through VSPDirect.com/EyeGiveBack, VSP will donate an eye exam and glasses to a child in need – up to a retail value of $1 million. Learn more at VSPDirect.com/EyeGiveBack.
Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) released a new report, “A Decade of Innovation in Rare Diseases,” to document the significant progress made in the last 10 years in understanding a broad range of rare diseases and translating this knowledge into groundbreaking therapies for a variety of patient populations.
The report illustrates that more than 230 new medicines to treat rare or “orphan” diseases were approved by the U.S. Food and Drug Administration (FDA) in the last decade, and there are currently more than 450 orphan drugs in development.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7350554-phrma-report-innovation-rare-diseases/
